🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Samantha J. Hutten

Michael J. Fox Foundation

ORCID: 0000-0002-8435-744X
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.7Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433
Top 12%
1.7DataRank
Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

Papers

Driven by 14 papers — median percentile 88. Top paper: “Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression”.

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression

Journal of Parkinson s Disease(2023)10.3233/jpd-223433
Top 12%
1.7DataRank
Top 12%66 citations

Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia +16 more

A proteogenomic view of Parkinson’s disease causality and heterogeneity

npj Parkinson s Disease(2023)10.1038/s41531-023-00461-9
N/A
1.4DataRank · unranked
56 citations

Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge L. Del‐Aguila +24 more

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

The Lancet Neurology(2015)10.1016/s1474-4422(15)00178-7
N/A
0.811DataRank · unranked
222 citations

Cory Y. McLean, Jacqueline Rick, Shirley Eberly, Samantha J. Hutten, Katrina Gwinn +40 more

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Movement Disorders(2020)10.1002/mds.28312
N/A
0DataRank · unranked
102 citations

Cornelis Blauwendraat, Hampton L. Leonard, Mary B. Makarious, Jonggeol J. Kim, Ganqiang Liu +43 more

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51164
N/A
0DataRank · unranked
40 citations

Pavlina Wolf, Ming Sum Ruby Chiang, Karolina Helesicova, Xiaokui Kate Zhang, Kalpana Merchant +15 more

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

Acta Neuropathologica Communications(2021)10.1186/s40478-021-01282-8
N/A
0DataRank · unranked
261 citations

Christina D. Orrú, Luis Concha‐Marambio, Simone Giaisi, Bradley R. Groveman, Carly M. Farris +13 more

Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI

npj Parkinson s Disease(2021)10.1038/s41531-021-00241-3
N/A
0DataRank · unranked
55 citations

Hye Jung Park, Ming Sum Ruby Chiang, Idil Tuncali, Ganqiang Liu, Joseph J. Locascio +9 more

Parkinson’s disease causality and heterogeneity: a proteogenomic view

medRxiv(2022)10.1101/2022.03.09.22272131
N/A
0DataRank · unranked
3 citations

Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge L. Del‐Aguila +24 more

Parkinson’s disease causality and heterogeneity: a proteogenomic view

Research Square(2022)10.21203/rs.3.rs-1787250/v1
N/A
0DataRank · unranked
1 citations

Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich +24 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1
N/A
0DataRank · unranked
1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2
N/A
0DataRank · unranked
42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000208033
N/A
0DataRank · unranked
23 citations

David J. Irwin, Thomas F. Tropea, Emma Rhodes, Jeffrey S. Phillips, Alice S. Chen-Plotkin +18 more

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement Disorders(2020)10.1002/mds.28206
N/A
0DataRank · unranked
201 citations

Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg +21 more

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

Annals of Neurology(2020)10.1002/ana.25811
N/A
0DataRank · unranked
111 citations

Janel Fedler, Christopher S. Coffey, Chelsea Caspell‐Garcia, Ju‐Hee Kang, Tanya Simuni +16 more